HIMSS20 cancelled over coronavirus risks

Amy Baxter | | Health Exec | Management
himss2.jpg

The Healthcare Information and Management Systems Society (HIMSS) has cancelled its 2020 conference scheduled for March 9-13 in Orlando, Florida, due to concerns and risks over the new coronavirus, COVID-19.

The association announced the decision on March 5, just a day after officials stated it would continue on with the conference as scheduled. HIMSS took into account reports from the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) as well as additional experts in this area when making its decision.

The European Society of Radiology conference scheduled for March 11-15 in Vienna was also recently cancelled.

See the full story below:

HIMSS cancels annual meeting over coronavirus concerns

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

More than 1,000 hospitals earn $700M opioid crisis judgment
CEO of Amazon’s One Medical steps down
Nonprofit academic hospital receives criticism after running Super Bowl ad
Hospital delays opening after vandals sledgehammer holes into walls
Cigna announces changes to improve prior authorization, customer satisfaction
UnitedHealthcare in dispute with maternity practice over $1M in claims

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.